Our data are consistent with recent studies exploring the physiological consequences of human mutations in the KCNJ11 gene that result in clinical developmental delay, epilepsy, and neonatal diabetes or DEND syndrome (50, 51). The gene discussed is KCNJ11; the disease is epilepsy.